The United States could safely reduce the frequency of tetanus and diphtheria booster shots for adults and save an estimated $1 billion per year, according to a new review led by researchers at Oregon Health & Science University.
This conclusion depends on the U.S. maintaining very high childhood vaccination rates.
Vaccines for tetanus and diphtheria are referred to as “legacy” vaccines by the healthcare industry because they were developed in the 1920s, during a time when the U.S. Food and Drug Administration was in its early stages of development.
Read More
